✦ LIBER ✦

729 High dose 5FU biomodulation by high dose leucovorin and individual 5FU dose adjustment in metastatic colorectal cancer. A multicentric prospective study of 130 patients

✍ Scribed by E. Gamelin; R. Delva; Y. Dumasnil; J. Jacob; Ph. Maillart; M. Boisdron Calle; M.-J. Goudier; A. Lortholary; A. Hardouin; J. Geslin; J. Hetroy; F. Larra

Book ID: 116167475
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 162 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95978-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose 5-fluorouracil (5-FU) and foli

High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study

✍ E. Jäger; O. Klein; B. Wächter; B. Müller; U. Braun; A. Knuth 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Plasma and salivary pharmacokinetics of

Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid

✍ J.M Joulia; F Pinguet; M Ychou; J Duffour; C Astre; F Bressolle 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 120 KB

A phase II study of alternating cycles o

A phase II study of alternating cycles of CPT-11 and high-dose 48 hour infusion 5-FU in combination with leucovorin (HD-5-FU/LV) in no selective patients with metastatic colorectal cancer (MCRC)

✍ G. Rosati; D. Bilancia; S. De Santis; A. Dinota; A. Rossi; L. Manzione 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A Phase II Study of Oxaliplatin, 5-Fluor

A Phase II Study of Oxaliplatin, 5-Fluorouracil, Leucovorin, and High-Dose Capecitabine in Patients With Metastatic Colorectal Cancer

✍ Sam J. Lubner; Noelle K. LoConte; Kyle D. Holen; William Schelman; James P. Thom 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 117 KB

A phase II pilot study of high-dose 24-h

A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study

✍ Robert P. Whitehead; Jacqueline K. Benedetti; James L. Abbruzzese; Bach Ardalan; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

358Early results of a large randomised t

358Early results of a large randomised trial of ‘tomudex’ (raltitrexed) versus 5-fluorouracil (5FU) plus high dose leucovorin (HDLV) in patients with advanced colorectal cancer (ACC)

✍ J.J. McAleer; G. Cocconi; G. van Hazel; E. Francois; J.Y. Douillard; K. Possinge 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 125 KB